JP2023553390A5 - - Google Patents
Info
- Publication number
- JP2023553390A5 JP2023553390A5 JP2023533391A JP2023533391A JP2023553390A5 JP 2023553390 A5 JP2023553390 A5 JP 2023553390A5 JP 2023533391 A JP2023533391 A JP 2023533391A JP 2023533391 A JP2023533391 A JP 2023533391A JP 2023553390 A5 JP2023553390 A5 JP 2023553390A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- car
- immune cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063120692P | 2020-12-02 | 2020-12-02 | |
| US63/120,692 | 2020-12-02 | ||
| US202163153666P | 2021-02-25 | 2021-02-25 | |
| US63/153,666 | 2021-02-25 | ||
| US202163212289P | 2021-06-18 | 2021-06-18 | |
| US63/212,289 | 2021-06-18 | ||
| US17/476,661 | 2021-09-16 | ||
| US17/476,661 US11498973B2 (en) | 2018-04-12 | 2021-09-16 | BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof |
| PCT/US2021/061410 WO2022119923A1 (en) | 2020-12-02 | 2021-12-01 | Bcma-targeted chimeric antigen receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553390A JP2023553390A (ja) | 2023-12-21 |
| JP2023553390A5 true JP2023553390A5 (https=) | 2024-02-22 |
Family
ID=81853652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023533391A Pending JP2023553390A (ja) | 2020-12-02 | 2021-12-01 | Ｂｃｍａ標的化キメラ抗原受容体 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4255936A4 (https=) |
| JP (1) | JP2023553390A (https=) |
| KR (1) | KR20230117367A (https=) |
| CN (1) | CN116997345A (https=) |
| AU (1) | AU2021393434A1 (https=) |
| CA (1) | CA3201008A1 (https=) |
| WO (1) | WO2022119923A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250131823A (ko) * | 2023-03-31 | 2025-09-03 | 아벨제타 인크. | Cd20 및 bcma를 표적화하는 이중특이적 키메라 항원 수용체 |
| KR102869233B1 (ko) * | 2024-01-24 | 2025-10-15 | 주식회사 박셀바이오 | Bcma 특이적 키메라 항원 수용체를 포함하는 신규한 골수 침윤 림프구 집단 및 이의 제조방법 |
| WO2025171383A2 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens and related methods and uses |
| WO2025171388A1 (en) | 2024-02-09 | 2025-08-14 | Dispatch Biotherapeutics, Inc. | Engineered cancer antigens with modified domains and related methods and uses |
| WO2026006767A1 (en) | 2024-06-28 | 2026-01-02 | Dispatch Biotherapeutics, Inc. | Tethered il-9/il-9r and related engineered cells and methods |
| CN119119274A (zh) * | 2024-09-26 | 2024-12-13 | 北京昌盛鸿途生物科技有限公司 | 一种靶向bcma的cart细胞及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2766608C2 (ru) * | 2012-04-11 | 2022-03-15 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток |
| WO2018085690A1 (en) * | 2016-11-04 | 2018-05-11 | Bluebird Bio, Inc. | Anti-bcma car t cell compositions |
| CN116836297A (zh) * | 2018-04-12 | 2023-10-03 | 上海赛比曼生物科技有限公司 | 靶向bcma的嵌合抗原受体及其制法和应用 |
| JP7599205B2 (ja) * | 2018-06-01 | 2024-12-13 | アンヘレス セラピューティクス インコーポレイテッド | 細胞療法のための多様な抗原結合ドメイン、新規プラットフォームおよびその他の強化 |
| CA3105729A1 (en) * | 2018-07-31 | 2020-02-06 | Amgen Research (Munich) Gmbh | Dosing regimen for bcma-cd3 bispecific antibodies |
-
2021
- 2021-12-01 EP EP21901383.6A patent/EP4255936A4/en active Pending
- 2021-12-01 AU AU2021393434A patent/AU2021393434A1/en active Pending
- 2021-12-01 KR KR1020237020736A patent/KR20230117367A/ko active Pending
- 2021-12-01 JP JP2023533391A patent/JP2023553390A/ja active Pending
- 2021-12-01 CA CA3201008A patent/CA3201008A1/en active Pending
- 2021-12-01 CN CN202180081130.0A patent/CN116997345A/zh active Pending
- 2021-12-01 WO PCT/US2021/061410 patent/WO2022119923A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023553390A5 (https=) | ||
| US12129309B2 (en) | Heterodimeric antibodies that bind CD3 and CD38 | |
| IL317912A (en) | A combined chimeric antigen receptor targeting CD19 and CD20 and its applications | |
| JP7646361B2 (ja) | 抗ｐｖｒｉｇ／抗ｔｉｇｉｔ二重特異性抗体および使用方法 | |
| JP2025032091A5 (https=) | ||
| JP2023525778A5 (https=) | ||
| JP2020010699A5 (https=) | ||
| JP2017522879A5 (https=) | ||
| JP2017524367A5 (https=) | ||
| JP2020529970A5 (https=) | ||
| US20180305465A1 (en) | Heterodimeric antibodies that bind cd3 and cd38 | |
| US20230121135A1 (en) | Compositions and methods for targeting cd33-expressing cancers | |
| CN107660214A (zh) | 针对cd3和cd20的双特异性抗体 | |
| JP2024527557A5 (https=) | ||
| JP2024534847A5 (https=) | ||
| IL304857A (en) | Preparations and methods for treating HER2 POSITIVE cancer | |
| US20250043001A1 (en) | Anti-cd28 compositions | |
| WO2024184287A1 (en) | Combination therapy of an anti-egfrviii/anti-cd3 antibody and an tumor-targeted 4-1bb agonist | |
| JP2025505933A5 (https=) | ||
| KR20240155275A (ko) | 항 글루코코르티코이드 유도 tnfr 관련(gitr) 단백질 항체 및 이의 용도 | |
| NZ768183B2 (en) | Humanized bcma antibody and bcma-car-t cells | |
| RU2019123366A (ru) | Антитело, нацеленное на всма, и его применение | |
| HK1261817B (en) | Heterodimeric antibodies that bind cd3 and cd38 | |
| HK1261817A1 (en) | Heterodimeric antibodies that bind cd3 and cd38 |